Shanghai New World Co., Ltd (SHSE: 600628)
Health Care · Pharmaceuticals · CN
CN¥6.46
+1.57% today · -12.5% 1Y
Shanghai New World Co., Ltd (SHSE: 600628) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $623.88M and employs 1,144 people.
Over the last twelve months the share price has lost 12.5%, trading between 5.59 and 9.77.
Tweenvest scores Shanghai New World Co., Ltd across four factors: quality 68/100, value 58/100, growth 0/100, dividend 13/100. Its strongest factor is quality.
600628 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $623.88M
- Revenue (TTM)
- $162.98M
- P/E
- 64.08
- EPS
- 0.10
- Dividend yield
- 0.62%
- Beta (5Y)
- 0.16
- 52-week high
- CN¥9.77
- 52-week low
- CN¥5.59
- Avg volume (3M)
- —
- Shares outstanding
- 646.88M
- Employees
- 1,144
- Next earnings
- —
About Shanghai New World Co., Ltd
Shanghai New World Co., Ltd. owns and operates department stores in China. The company produce and distributes Chinese herbal medicines; and sells Chinese patent medicines, western medicines, ginseng and antler tonics, and nutritional health products. It also involved in hotel, investment consulting and management, property and project management, advertising, dining, entertainment, e-commerce, clothing, trading, tourism, leisure, and retail pharmaceutical businesses, as well as provides Chinese herbal medicine consultation and prescription services. The company was founded in 1988 and is headquartered in Shanghai, China.
- ISIN
- CNE0000006X1
- Founded
- 1988
- Listed since
- Jan 19, 1993
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| TTY Biopharm Company LimitedTPEX: 4105 | $629.11M | NT$80.90 | +2.53% |
| Senores Pharmaceuticals LimitedNSEI: SENORES | $628.13M | Rs1,320.00 | -2.19% |
| Wuhan Hvsen Biotechnology Co.,Ltd.SZSE: 300871 | $625.65M | CN¥20.91 | -0.90% |
| Henan Taloph Pharmaceutical Stock Co.,LtdSHSE: 600222 | $625.37M | CN¥7.78 | -1.39% |
| Sun Pharma Advanced Research Company LimitedNSEI: SPARC | $622.35M | Rs185.60 | -1.14% |
| Jinling Pharmaceutical Company LimitedSZSE: 000919 | $619.32M | CN¥6.67 | +2.62% |
| Zhuhai Rundu Pharmaceutical Co., Ltd.SZSE: 002923 | $612.48M | CN¥12.25 | +11.06% |
| Komipharm International Co., Ltd.KOSDAQ: A041960 | $611.29M | ₩11,360.00 | +14.98% |
Figures last refreshed Oct 11, 2026.